RESUMEN
Keloid disease (KD) is a common connective tissue disorder of unknown aetiopathogenesis with ill-defined treatment. Keloid scars present as exophytic fibroproliferative reticular lesions post-cutaneous injury, remain benign yet behave locally aggressive and expansive. To date, there is limited understanding, and validation of biomarkers identified through combined proteomic and genomic evaluation of KD. Therefore, the aim here was to identify putative-causative candidates in KD, by performing a comprehensive proteomics analysis of subcellular fractions as well as the whole cell, coupled with transcriptomics data analysis of normal compared with KD fibroblasts. We then applied novel integrative bioinformatics analyses to demonstrate that NF-kappa-Beta-p65 (RELA) from the cytosolic fraction and Calpain-2 (CAPN2) from the whole cell lysate were significantly up-regulated in KD and associated with alterations in relevant key signalling pathways including apoptosis. Our findings were further confirmed by showing upregulation of both RELA and CAPN2 in KD using flow cytometry and immunohistochemistry. Moreover, functional evaluation using real-time cell analysis and flow cytometry, demonstrated that both omeprazole and dexamethasone inhibited the growth of KD fibroblasts by enhancing the rate of apoptosis. In conclusion, to our knowledge previously unreported, subcellular fractionation and metaproteogenomic analyses have identified two novel biomarkers of relevance to keloid diagnostics and therapeutics.
RESUMEN
Urine is a complex biofluid that reflects both overall physiologic state and the state of the genitourinary tissues through which it passes. It contains both secreted proteins and proteins encapsulated in tissue-derived extracellular vesicles (EVs). To understand the population variability and clinical utility of urine, we quantified the secreted and EV proteomes from 190 men, including a subset with prostate cancer. We demonstrate that a simple protocol enriches prostatic proteins in urine. Secreted and EV proteins arise from different subcellular compartments. Urinary EVs are faithful surrogates of tissue proteomes, but secreted proteins in urine or cell line EVs are not. The urinary proteome is longitudinally stable over several years. It can accurately and non-invasively distinguish malignant from benign prostatic lesions and can risk-stratify prostate tumors. This resource quantifies the complexity of the urinary proteome and reveals the synergistic value of secreted and EV proteomes for translational and biomarker studies.
Asunto(s)
Vesículas Extracelulares , Neoplasias de la Próstata , Proteoma , Humanos , Neoplasias de la Próstata/orina , Neoplasias de la Próstata/metabolismo , Neoplasias de la Próstata/patología , Masculino , Vesículas Extracelulares/metabolismo , Proteoma/metabolismo , Anciano , Biomarcadores de Tumor/orina , Biomarcadores de Tumor/metabolismo , Proteómica/métodos , Persona de Mediana Edad , Próstata/metabolismo , Próstata/patología , Línea Celular TumoralRESUMEN
BACKGROUND: In the United States, Black men are at highest risk for being diagnosed with and dying from prostate cancer. Given this disparity, we examined relevant data to establish clinical prostate-specific antigen (PSA) screening guidelines for Black men in the United States. METHODS: A comprehensive literature search identified 1848 unique publications for screening. Of those screened, 287 studies were selected for full-text review, and 264 were considered relevant and form the basis for these guidelines. The numbers were reported according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. RESULTS: Three randomized controlled trials provided Level 1 evidence that regular PSA screening of men 50 to 74 years of age of average risk reduced metastasis and prostate cancer death at 16 to 22 years of follow-up. The best available evidence specifically for Black men comes from observational and modeling studies that consider age to obtain a baseline PSA, frequency of testing, and age when screening should end. Cohort studies suggest that discussions about baseline PSA testing between Black men and their clinicians should begin in the early 40s, and data from modeling studies indicate prostate cancer develops 3 to 9 years earlier in Black men compared with non-Black men. Lowering the age for baseline PSA testing to 40 to 45 years of age from 50 to 55 years of age, followed by regular screening until 70 years of age (informed by PSA values and health factors), could reduce prostate cancer mortality in Black men (approximately 30% relative risk reduction) without substantially increasing overdiagnosis. CONCLUSIONS: These guidelines recommend that Black men should obtain information about PSA screening for prostate cancer. Among Black men who elect screening, baseline PSA testing should occur between ages 40 and 45. Depending on PSA value and health status, annual screening should be strongly considered. (Supported by the Prostate Cancer Foundation.).
Asunto(s)
Negro o Afroamericano , Detección Precoz del Cáncer , Antígeno Prostático Específico , Neoplasias de la Próstata , Masculino , Humanos , Neoplasias de la Próstata/diagnóstico , Neoplasias de la Próstata/etnología , Neoplasias de la Próstata/sangre , Antígeno Prostático Específico/sangre , Estados Unidos/epidemiología , Persona de Mediana Edad , Anciano , Guías de Práctica Clínica como Asunto , Tamizaje MasivoRESUMEN
Biofluids contain molecules in circulation and from nearby organs that can be indicative of disease states. Characterizing the proteome of biofluids with DIA-MS is an emerging area of interest for biomarker discovery; yet, there is limited consensus on DIA-MS data analysis approaches for analyzing large numbers of biofluids. To evaluate various DIA-MS workflows, we collected urine from a clinically heterogeneous cohort of prostate cancer patients and acquired data in DDA and DIA scan modes. We then searched the DIA data against urine spectral libraries generated using common library generation approaches or a library-free method. We show that DIA-MS doubles the sample throughput compared to standard DDA-MS with minimal losses to peptide detection. We further demonstrate that using a sample-specific spectral library generated from individual urines maximizes peptide detection compared to a library-free approach, a pan-human library, or libraries generated from pooled, fractionated urines. Adding urine subproteomes, such as the urinary extracellular vesicular proteome, to the urine spectral library further improves the detection of prostate proteins in unfractionated urine. Altogether, we present an optimized DIA-MS workflow and provide several high-quality, comprehensive prostate cancer urine spectral libraries that can streamline future biomarker discovery studies of prostate cancer using DIA-MS.
Asunto(s)
Neoplasias de la Próstata , Proteoma , Proteómica , Humanos , Masculino , Neoplasias de la Próstata/orina , Neoplasias de la Próstata/diagnóstico , Proteoma/análisis , Proteómica/métodos , Próstata/metabolismo , Próstata/patología , Biblioteca de Péptidos , Biomarcadores de Tumor/orina , Espectrometría de Masas en Tándem/métodos , Flujo de TrabajoRESUMEN
Importance: Diversity is an essential element of an effective health care system. A key to developing a diverse workforce is establishing a diverse student population in health professions programs. Objective: To examine the diversity of students in Doctor of Medicine (MD), Doctor of Osteopathic Medicine (DO), Doctor of Dental Surgery (DDS), Doctor of Dental Medicine (DMD), and Doctor of Pharmacy (PharmD) programs with emphasis on the trends of underrepresented minoritized groups (American Indian or Alaska Native, Black or African American, Hispanic or Latino, and Native Hawaiian or Other Pacific Islander) and sex relative to the overall age-adjusted US population. Design, Setting, and Participants: This cross-sectional study used deidentified, self-reported data from 2003 to 2019 from the Association of American Medical Colleges, American Association of Colleges of Osteopathic Medicine, American Dental Education Association, American Dental Association, and American Association of Colleges of Pharmacy. Data analysis was performed from 2003 to 2004 and from 2018 to 2019. Exposures: Data on the race, ethnicity, and sex of applicants, matriculants, and degrees conferred by health professions programs were collected and compared with the age-adjusted population in the US Census (aged 20-34 years) over time. Main Outcomes and Measures: The main outcomes were trends in the proportions of underrepresented minoritized groups and sex diversity among applicants, matriculants, and degrees conferred relative to the overall age-adjusted US population. Trends were measured using the representation quotient, which is defined as the ratio of the proportion of each subgroup to the total population of applicants, matriculants, or graduates relative to the proportion for that subgroup within the US Census population of similar age. Regression analysis was used to evaluate the trend over time. Results: A total of 594â¯352 applicants were analyzed across the examined programs. From 2003 to 2019, the proportions of individuals from underrepresented groups increased for DDS and DMD (applicants, from 1003 of 8176 to 1962 of 11â¯298 [5.1%]; matriculants, from 510 of 4528 to 966 of 6163 [4.2%]; degrees awarded, from 484 of 4350 to 878 of 6340 [2.7%]), PharmD (applicants, from 9045 of 71â¯966 to 11â¯653 of 50â¯482 [9.0%]; matriculants, from 5979 of 42â¯627 to 10â¯129 to 62â¯504 [6.3%]; degrees awarded, from 922 of 7770 to 2190 of 14â¯800 [3.0%]), and DO (applicants, from 740 of 6814 to 3478 of 21â¯090 [5.4%]; degrees awarded, 199 of 2713 to 582 of 6703 [1.4%]) programs, but decreased for MD programs (applicants, from 6066 of 34â¯791 to 7889 of 52â¯777 [-2.3%]; matriculants, 2506 of 16â¯541 to 2952 of 21â¯622 [-2.4%]; degrees awarded, from 2167 of 15â¯829 to 2349 of 19â¯937 [-0.1%]). Compared with age-adjusted US Census data, all programs had more Asian students and fewer male, American Indian or Alaska Native, Black or African American, Hispanic or Latino, and Native Hawaiian or Other Pacific Islander students (representation quotient <1). Conclusions and Relevance: In this cross-sectional study, most of the health professions in the study saw increases in underrepresented minority applicants, matriculants, and degrees conferred from 2003 to 2019; however, all programs were below the age-adjusted US Census data. The increased racial, ethnic, and sex diversity in the programs illustrates progress, but additional strategies are needed to achieve a more representative health care workforce.
Asunto(s)
Empleos en Salud , Farmacia , Estados Unidos , Humanos , Masculino , Estudios Transversales , Personal de Salud , EtnicidadRESUMEN
In our area, there is dearth of accurate sex education that could equip adolescents in making informed decisions on sexual issues. This scenario has been linked to a high prevalence of sexual risk behaviors, consequences and poor choices with regard to solutions. Objective: To determine the awareness, gender variations, consequences of sexual risk behavior, and adopted solutions among senior secondary school adolescents in Owerri, Nigeria. Methodology: This was a cross sectional survey of 384 in-school adolescents in Owerri, Nigeria, selected using a multistage sampling technique. Data were collected using pretested self-administered semi- structured questionnaires. Data were analyzed using SPSS v.22 (p<0.05). Results: The majority of adolescents, i.e. 306 (82.5%), were aware of sexual risk behaviors, 340 (91.6%) had received some sex education, and 296 (79.8%) were aware of contraceptives. Key sources of information on sexuality were schools and parents. In total, 54 (14.1%) participants were sexually active, 12 (22.2%) reported ever having an STI, and 9 (75%) had been treated in hospital. Also, 8 (14.8%) of the 54 had dealt with a pregnancy; 7 (87.5%) had undergone an abortion, 3 (42.9%) in a hospital. Sexual risk behaviors among males were associated with age (p=0.002), school type (p=0.002), and alcohol intake (p=0.000), while the residence of the parents had a stronger influence among females (p=0.014). Conclusions: This study found high awareness of sexual issues, mainly sourced from schools and parents. Associations were made between sexual risk behaviors and gender differences (age, school type, and alcohol intake in males, parental residence among females). The consequences of sexual risk behaviors were early pregnancy and STIs, with poor solutions adopted.